Medco Contract With AIG Shows That “Transparency” Pays Off, PBM Says
Medco's contract with AIG shows that "transparency" can offer a competitive advantage in the pharmacy benefit management sector, Medco CEO David Snow maintained during the Banc of America Securities conference in Las Vegas May 20
You may also be interested in...
The Medco injunction reflects the principle that pharmacy benefit management companies should be responsible for the "consequences" of therapeutic interchange, Associate U.S. Attorney James Sheehan said during a May 11 teleconference sponsored by Pharma Audioconferences
Prosecutors expect that other pharmacy benefit management companies will adopt codes of conduct based on Medco's April 26 settlement with 20 state attorneys general and the U.S. Attorney in Philadelphia
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011